Purple Biotech (PPBT) — Cash Flow Quality Index

Latest as of June 2026: -5.68x

Purple Biotech (PPBT) has a Cash Flow Quality Index of -5.68x as of June 2026. Operating cash flow of $-2.50 Million is below net income of $441.00K, suggesting accrual-heavy earnings not yet converted to cash. Explore Purple Biotech cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.

Cash Flow Quality Index

-5.68x

Operating CF / Net Income

Operating Cash Flow

$-2.50 Million

USD

Net Income

$441.00K

USD

Data as of

Jun 2026

Most recent filing

Annual Cash Flow Quality Index for Purple Biotech (None–None)

Year-by-year earnings quality comparison for Purple Biotech.

Year	Quality Index	Operating CF (USD)	Net Income	YoY Change

Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.